PROTEOMICS 2026 Johannes Bruno Mueller
Max Planck Institute of Biochemistry, BAYERN, Germany
Presentations this author is a contributor to:
Bridging clinical ontologies and proteomics to overcome statistical limitations in rare disease research (133011)
11:55 AM
Ericka Corazon Itang
Symposium Three | Disease Proteomics I